FindTrial
Sign In

A study of laser treatment given after cataract surgery

Retrospective study of Nd YAG capsulotomy after phacoemulsification - NdYAG

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2014/12/005325
Enrollment
200
Registered
2014-12-26
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients with posterior Capsular Opacification

Interventions

Intervention1: Nd YAG Capsulotomy: Nd YAG Capsulotomy for the treatment of Posterior Capsular Opacification.The laser is given through a slit lamp,around 20 to 25 shots are given to the intra ocular l

Sponsors

NETHRADHAMA SUPERSPECIALITY EYE HOSPITAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Uncomplicated phacoemulsification surgery in our institution 2) Capsulotomy done by Continuous Curvilinear Capsulorrhexis (CCC) 3) Foldable IOL implantation 4) Absence of primary PCO

Exclusion criteria

Exclusion criteria: 1. Conditions like diabetes, pseudoexfoliation, Uveitis, trauma which may accelerate the process of PCO formation 2. Patients with glaucoma, any corneal or retinal pathology which may not lead to improvement of vision following Nd YAG capsulotomy

Design outcomes

Primary

MeasureTime frame
AcrySof IOLS have a low incidence of PCO when compared to PMMA IOLsTimepoint: Acrysof iol developed pco in 12 percent cases whereas in PMMA lenses its 30 percent. Acrysof iol developed pco in 3 yrs whereas PMMA iol developed pco in 2 years—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDr Sri Ganesh

Nethradhama Superspeciality Eye Hospital

phacomaverick@gmail.com08026088000

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026